Adrenal crisis mainly manifested as recurrent syncope secondary to tislelizumab: a case report and literature review

Overview of attention for article published in Frontiers in immunology, January 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 33,578 followers.

RT @FrontImmunol: New Research: Adrenal crisis mainly manifested as recurrent syncope secondary to tislelizumab: a case report and literatu…

17 Jan 2024

Reply Repost Favourite

New Research: Adrenal crisis mainly manifested as recurrent syncope secondary to tislelizumab: a case report and literature review: As an immune checkpoint inhibitor (ICI), tislelizumab is an anti-programmed cell death protein 1 (PD-1) drug.… https://t.co/

17 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.